ArticleAmerican journal of cancer research2018

A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity.

Yuh-Pyng Sher et al.PubMed ↗Full text ↗

No numbers read from the abstract.